Fanti, Iuri
 Distribuzione geografica
Continente #
EU - Europa 1.052
NA - Nord America 898
AS - Asia 184
AF - Africa 12
SA - Sud America 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.152
Nazione #
US - Stati Uniti d'America 895
DE - Germania 333
SE - Svezia 138
FR - Francia 131
PL - Polonia 127
CN - Cina 112
UA - Ucraina 111
IT - Italia 100
IE - Irlanda 47
IN - India 44
GB - Regno Unito 33
FI - Finlandia 28
TR - Turchia 13
IR - Iran 9
CM - Camerun 8
BR - Brasile 4
HK - Hong Kong 4
MX - Messico 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
CA - Canada 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
EU - Europa 1
JP - Giappone 1
MA - Marocco 1
NL - Olanda 1
RU - Federazione Russa 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 2.152
Città #
Chandler 208
Kraków 126
Jacksonville 75
Ashburn 73
San Mateo 52
Dublin 47
New York 47
Dearborn 37
Milan 33
Nanjing 33
Redmond 32
Cattolica 29
Lawrence 24
Wilmington 23
Redwood City 19
Nürnberg 18
Nanchang 17
Houston 15
Lancaster 13
Boston 12
Izmir 12
Shenyang 11
Seattle 10
Detroit 9
Hebei 9
Woodbridge 9
Ann Arbor 8
Bremen 7
Changsha 7
Fairfield 7
Mountain View 7
Verona 7
Beijing 6
Rome 6
Leawood 5
Norwalk 5
Tianjin 5
Cambridge 4
Hefei 4
Kunming 4
Boardman 3
Jiaxing 3
Munich 3
Princeton 3
Siena 3
University Park 3
Washington 3
Central District 2
Changchun 2
Edinburgh 2
Fuzhou 2
Hangzhou 2
Hong Kong 2
Kish 2
Marseille 2
Palermo 2
Petriolo 2
Philadelphia 2
Phoenix 2
Pune 2
Shanghai 2
Abidjan 1
Amsterdam 1
Andover 1
Ardabil 1
Auburn Hills 1
Augusta 1
Aydogan 1
Bangalore 1
Berlin 1
Bern 1
Busto Arsizio 1
Centurion 1
Clearwater 1
Collegeville 1
Dallas 1
Dubai 1
Frankfurt am Main 1
Fremont 1
Guangzhou 1
Helsinki 1
Hounslow 1
Indiana 1
Jinan 1
Kashan 1
Leipzig 1
Los Angeles 1
Mcallen 1
Mumbai 1
Phoenixville 1
Rabat 1
Rio Pardo de Minas 1
Saint Louis 1
San Francisco 1
San Jose 1
Sofia 1
Southwark 1
Sovicille 1
São Paulo 1
Tappahannock 1
Totale 1.163
Nome #
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 164
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 159
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients 125
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 101
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 100
Relationship between self-reported adherence, antiretroviral drug concentration measurement and self-reported symptoms in patients treated for HIV-1 infection 99
Predictors of first-line antiretroviral therapy discontinuation due to drug-related adverse events in HIV-infected patients: a retrospective cohort study 96
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 96
Effect of aging and human immunodeficiency virus infection on cognitive abilities 93
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction? 91
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 89
Detection of HLA-B*57:01 by real-time PCR: implementation into routine clinical practice and additional validation data 86
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons 80
Total cellular HIV-1 DNA decreases after switching to raltegravir-based regimens in patients with suppressed HIV-1 RNA 77
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL 76
Declining Prevalence of HIV-1 Drug Resistance in Antiretroviral Treatment-exposed Individuals in Western Europe 75
Long term follow-up of Nevirapine-treated patients in a single centre cohort 72
Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy 71
Response to first-line ritonavir-boosted protease inhibitors (PI/r)-based regimens in HIV positive patients presenting to care with low CD4 counts: Data from the Icona Foundation Cohort 68
A novel methodology for large-scale phylogeny partition 62
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen 59
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 54
Update on emergence of HIV-1 resistance to antiretroviral drug classes in an Italian national database: 2007-2009 52
Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition 43
Switch of predicted HIV-1 tropism in treated subjects and its association with disease progression 41
Robust supervised and unsupervised statistical learning for HIV type 1 coreceptor usage analysis 37
Totale 2.166
Categoria #
all - tutte 6.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201931 0 0 0 0 0 0 0 0 0 0 25 6
2019/2020322 75 19 15 8 36 35 23 14 19 14 42 22
2020/2021205 6 23 5 21 30 18 23 1 34 5 34 5
2021/2022214 23 22 4 18 8 12 1 35 10 18 30 33
2022/2023474 57 70 38 77 45 60 6 40 61 3 10 7
2023/2024188 16 66 5 21 9 54 10 3 1 2 1 0
Totale 2.166